Literature DB >> 2697477

Parathyroid hormone-related protein in hypercalcaemia of malignancy.

T J Martin1, L J Suva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697477     DOI: 10.1111/j.1365-2265.1989.tb01288.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  21 in total

Review 1.  Parathyroid hormone-like peptide.

Authors:  Daniel J Drucker
Journal:  Endocr Pathol       Date:  1991-03       Impact factor: 3.943

2.  Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.

Authors:  N J Bundred; J Walls; W A Ratcliffe
Journal:  Ann R Coll Surg Engl       Date:  1996-07       Impact factor: 1.891

Review 3.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

4.  Parathyroid hormone related protein and hypercalcaemia in breast cancer.

Authors:  N J Bundred; W A Ratcliffe; R A Walker; S Coley; J M Morrison; J G Ratcliffe
Journal:  BMJ       Date:  1991-12-14

5.  Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch.

Authors:  M Yamamoto; S C Harm; W A Grasser; M A Thiede
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner.

Authors:  Toshio Nakajima; Yoshitaka Konda; Masashi Kanai; Yoshio Izumi; Naoki Kanda; Apichart Nanakin; Sohei Kitazawa; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 7.  Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  C J Dunn; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

8.  Malignant phaeochromocytoma and hypercalcaemia.

Authors:  J A Bridgewater; W A Ratcliffe; N J Bundred; C W Owens
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

Review 9.  RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases.

Authors:  Hisataka Yasuda
Journal:  World J Orthop       Date:  2013-10-18

10.  Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy.

Authors:  A C Hutchesson; F Dunne; N J Bundred; H Gee; W A Ratcliffe
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.